|Last Price||Today's Change||52-Week Range||Trading Volume|
|28.92||0.10 (+0.35%)||27.76 - 32.96||16.3 million (Below Avg)|
Market data as of 4:00PM 08/22/14. Quotes are delayed by at least 15 min.
U.S. FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE Following Initial Therapy
08/21/2014 1:31 PM ET